Investigation
of Obesity-Alleviation Effect of Eurycoma longifolia on Mice Fed with a High-Fat Diet
through Metabolomics Revealed Enhanced Decomposition and Inhibition
of Accumulation of Lipids
posted on 2021-04-15, 18:40authored byDingkun Zhang, Wen Zheng, Xin Li, Ge Liang, Nan Ye, Yueqiu Liu, Ang Li, Xin Liu, Rui Zhang, Jingqiu Cheng, Hao Yang, Meng Gong
The metabolic and bioactivity effects
of Eurycoma
longifolia (Eucalyptus longifolia) in obesity treatment were studied in mice fed with a high-fat diet
using a metabolomics approach. Aqueous extracts of E. longifolia were obtained via grinding, dissolving,
and freeze-drying. The hepatic steatosis effect of E. longifolia was characterized by hematoxylin and
eosin histological staining. External performance of the obesity-alleviation
effect was monitored by measuring body and food weight. In addition,
the metabolomics analysis of the E. longifolia–mice interaction system was performed using the established
platform combining liquid chromatography-tandem mass spectrometry
with statistical analysis. The presence and spatial distribution patterns
of differential molecules were further evaluated through desorption
electrospray ionization-mass spectrometry imaging. The results showed
that E. longifolia played a vital role
in downregulating lipid accumulation (especially triacylglycerols)
and fatty acids biosynthesis together with enhanced lipid decomposition
and healing in Bagg albino mice. During such a process, E. longifolia mainly induced metabolomic alterations
of amino acids, organic acids, phospholipids, and glycerolipids. Moreover,
under the experimental concentrations, E. longifolia induced more fluctuations of aqueous-soluble metabolites in the
plasma and lipids in the liver than in the kidneys. This study provides
an advanced alternative to traditional E. longifolia-based studies for evaluating the metabolic effects and bioactivity
of E. longifolia through metabolomics
technology, revealing potential technological improvement and clinical
application.